Law Firm Investigates Option Care Health, PTC, and RXO Merger Terms
Halper Sadeh LLC has launched an investigation into potential fiduciary duty breaches concerning the pending sales of Option Care Health, PTC, and RXO.
Investor rights law firm Halper Sadeh LLC is investigating the proposed sales of Option Care Health, PTC Inc., and RXO Inc. for potential violations of federal securities laws and breaches of fiduciary duties. The firm is evaluating whether the terms negotiated by the boards of directors adequately protect the interests of ordinary shareholders.
The inquiry focuses on three separate transactions: Option Care Health’s sale to CD&R and McKesson at $32.05 per share; PTC Inc.’s cash deal with Schneider Electric at $205.00 per share; and RXO Inc.’s merger with C.H. Robinson Worldwide, which involves a mix of cash and stock.
Halper Sadeh suggests that these transactions may contain provisions that discourage superior competing offers, potentially disadvantaging shareholders in favor of insiders. The firm has indicated it may pursue legal remedies, including requests for increased consideration or additional disclosures, on behalf of investors.
These investigations serve as a check on corporate deal-making, ensuring that the valuation processes leading to major acquisitions are transparent and that individual shareholders are not sidelined during structural changes.